Infective endocarditis is rare in patients with hematologic malignancy and neutropenia
Transplant Infectious Disease · 2024
DOI: 10.1111/tid.14302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Michael J Scolarici und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, University of Wisconsin, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Neutropenia, Hematologic Neoplasms, Bacteremia, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Infective endocarditis (IE) is a serious complication of bloodstream infections (BSIs) that occurs at variable rates depending on the pathogen and clinical setting. There is a paucity of data describing the risk of IE in patients with hematologic malignancy who develop bacteremia while neutropenic.
Methods
Adult patients on the hematology ward from January 2018 to December 2020 with hematologic malignancy and bacteremia were evaluated retrospectively for endocarditis by applying the 2023 Duke‐ISCVID criteria. Charts of possible cases were evaluated 90 days after the initial BSI for new infectious complications that could indicate missed IE. Descriptive statistics compared patients admitted for hematopoietic stem cell transplantation (HSCT) to those admitted for alternative reasons (non‐HSCT).
Results
Among the 1005 positive blood cultures initially identified, there were 66 episodes in 65 patients with hematologic malignancy and at least grade 3 neutropenia for a mean duration of 11.4 days during their admission. Transthoracic echocardiography (TTE) was performed in 34.8% of BSIs, and transesophageal echocardiography (TEE) in 6.1%. There were no new infectious complications in possible cases 90 days after their initial BSI. No cases of endocarditis were identified.
Conclusions
Endocarditis is rare amongst patients with hematologic malignancy, bacteremia, and neutropenia, and no cases were identified in this cohort. The use of routine TTE in this setting seems unwarranted, and the addition of TEE is unlikely to improve patient‐centered outcomes. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Infectious Diseases, University of Wisconsin, Madison, Wisconsin, USA.
- University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
- Department of Medicine, Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA.
ORCID-Profile: Michael J Scolarici, Jeannina Smith, Christopher Saddler
Zitieren
APA
Scolarici, M. J., Berman, L. R., Callander, N., Smith, J., & Saddler, C. (2024). Infective endocarditis is rare in patients with hematologic malignancy and neutropenia. Transplant Infectious Disease. https://doi.org/10.1111/tid.14302
Vancouver
Scolarici MJ, Berman LR, Callander N, Smith J, Saddler C. Infective endocarditis is rare in patients with hematologic malignancy and neutropenia. Transplant Infectious Disease. 2024. doi:10.1111/tid.14302
BibTeX
@article{Scolarici2024,
author = {Scolarici, Michael J and Berman, Leigh R and Callander, Natalie and Smith, Jeannina and Saddler, Christopher},
title = {Infective endocarditis is rare in patients with hematologic malignancy and neutropenia},
journal = {Transplant Infectious Disease},
year = {2024},
doi = {10.1111/tid.14302}
}
EUVIMED